Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
polyethylene glycol (1 trial)
Dry Eye Syndromes (Phase 4)
Keratoconjunctivitis Sicca (Phase 4)
Trials (1 total)
Trial APIs (1 total)